Miret C - Search Results

1

Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.

Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M. Miret C, et al. Anticancer Res. 1999 Jul-Aug;19(4B):3073-6. Anticancer Res. 1999. PMID: 10652595

2

Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.

Miret C, Molina R, Filella X, García-Carrasco M, Claver G, Ingelmo M, Ballesta A, Font J. Miret C, et al. Tumour Biol. 2003 Aug-Sep;24(4):185-8. doi: 10.1159/000074428. Tumour Biol. 2003. PMID: 14654712

3

Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus.

Font J, Vidal J, Cervera R, López-Soto A, Miret C, Jiménez de Anta MT, Ingelmo M. Font J, et al. Among authors: miret c. Lupus. 1995 Feb;4(1):47-9. doi: 10.1177/096120339500400110. Lupus. 1995. PMID: 7767339

4

Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.

Font J, López-Soto A, Cervera R, Casals FJ, Reverter JC, Muñoz FJ, Miret C, Bové A, Ordinas A, Ingelmo M. Font J, et al. Among authors: miret c. Thromb Res. 1997 Apr 1;86(1):37-48. doi: 10.1016/s0049-3848(97)00043-1. Thromb Res. 1997. PMID: 9172285

5

Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

Muñoz-Rodríguez FJ, Font J, Badia JR, Miret C, Barberà JA, Cervera R, Ingelmo M. Muñoz-Rodríguez FJ, et al. Among authors: miret c. Lupus. 1997;6(4):412-4. doi: 10.1177/096120339700600413. Lupus. 1997. PMID: 9175030

6

Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.

López-Soto A, Cervera R, Font J, Bové A, Reverter JC, Muñoz FJ, Miret C, Espinosa G, Ordinas A, Ingelmo M. López-Soto A, et al. Among authors: miret c. Clin Exp Rheumatol. 1997 Mar-Apr;15(2):143-9. Clin Exp Rheumatol. 1997. PMID: 9196865

7

Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?

Miret C, Cervera R, Reverter JC, García-Carrasco M, Ramos M, Mollà M, Font J, Ingelmo M. Miret C, et al. Clin Exp Rheumatol. 1997 Sep-Oct;15(5):541-4. Clin Exp Rheumatol. 1997. PMID: 9307863

8

Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.

Miret C, Font J, Molina R, Filella X, Vivancos J, Muñoz-Rodriguez FJ, Cervera R, Ballesta AM, Ingelmo M. Miret C, et al. Anticancer Res. 1998 Mar-Apr;18(2B):1341-4. Anticancer Res. 1998. PMID: 9615813

9

Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.

Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M. Miret C, et al. Anticancer Res. 2001 Jul-Aug;21(4B):3053-9. Anticancer Res. 2001. PMID: 11712810

10

Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.

García-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Muñoz FJ, Miret C, Espinosa G, Ingelmo M. García-Carrasco M, et al. Among authors: miret c. Ann Rheum Dis. 1997 Mar;56(3):173-5. doi: 10.1136/ard.56.3.173. Ann Rheum Dis. 1997. PMID: 9135219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters